Chao WANG
5Patents
0h-index
7Co-inventors
30Inventor score
Filing activity: Jan 11, 2017 → May 21, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12233059B2 | Effective treatment of depression in patients having impaired learning and/or memory or certain EEG characteristics with a benzylpiperazine-aminopyridine agent | Human Necessities | 0 | Active |
| US11369651B2 | Uses of FU-LING (Poria cocos) extract and tumulosic acid in protecting muscles | Human Necessities | 0 | Active |
| US9931367B2 | Uses of cistanche tubulosa extract and isoacteoside in protecting muscle | Human Necessities | 0 | Active |
| US12208096B2 | Effective treatment of depression in patients having impaired learning and/or memory or certain EEG characteristics with a benzylpiperazine-aminopyridine agent | Human Necessities | 0 | Active |
| US10973863B2 | Method for regulating, preventing and/or treating pulmonary injury | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.